All In MedTech

Device Trial Radar · NCT03385109

The TransEnterix European Patient Registry

The TransEnterix European Patient Registry for Robotic Assisted Laparoscopic Procedures in Urology, Abdominal Surgery, Thoracic and Gynecologic Surgery

Last checked: Nov 19, 2026Latest source record: Aug 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

4,080

Actual

Start

Jul 25, 2017

Primary completion

Jun 17, 2026

Study completion Jun 17, 2026

Sponsor

Lead sponsor
Asensus SurgicalNot on our public-company list
Sponsor type
Industry
Collaborators
RQM+
First posted
Dec 28, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open label observational registry trial in which participating centers enroll subjects who had or will have a laparoscopically assisted surgery using the Senhance Surgical System.

Conditions

  • Surgery

Interventions

  • SurgeryDevice

    Patients are approached surgically with the Senhance Surgical System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventTime frame: Surgery to 30 days post op

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • St. Marien-Krankenhaus

    Siegen, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.